TOKYO - The Japanese government approved Thursday the use of the anti-viral drug remdesivir for novel coronavirus patients in an expedited review as Japan, like other countries, scrambles to contain COVID-19 with the death toll gradually rising.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
